Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVN1000 Gel in Acne Vulgaris
NCT01844752Phase 2Completed
- Sponsor
- Novan
- Start
- Apr 2013
- Primary completion
- Nov 2013
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of berdazimer in acne vulgaris, sponsored by Novan. Started Apr 2013; status: completed.
02
Drugs
berdazimer
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01844752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844752.